La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Association between megakaryocyte abnormalities on bone marrow smear and response to thrombopoietin receptor agonists in adult patients with primary immune thrombocytopenia
Infections in non-splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect
G. Moulis, M. Lapeyre-Mestre, A. Palmaro and L. Sailler Journal of Thrombosis and Haemostasis 15(4) 785 (2017) https://doi.org/10.1111/jth.13622
Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort
Guillaume Moulis, Johanne Germain, Thibault Comont, Natacha Brun, Claire Dingremont, Brice Castel, Sophie Arista, Laurent Sailler, Maryse Lapeyre‐Mestre, Odile Beyne‐Rauzy, Bertrand Godeau and Daniel Adoue American Journal of Hematology 92(6) 493 (2017) https://doi.org/10.1002/ajh.24702
Validation of an algorithm identifying incident primary immune thrombocytopenia in the French national health insurance database
Salim Mezaache, Helene Derumeaux, Pierre Ferraro, Pascal Capdepon, Jean‐Christophe Steinbach, Xavier Abballe, Deborah Palas, Nabil Saichi, Karine Desboeuf, Maryse Lapeyre‐Mestre, Laurent Sailler and Guillaume Moulis European Journal of Haematology 99(4) 344 (2017) https://doi.org/10.1111/ejh.12926
Validation of immune thrombocytopenia diagnosis code in the French hospital electronic database
Fonction de risque d’infection grave des corticoïdes dans la thrombopénie immunologique primaire persistante ou chronique. Étude cas-témoins nichée dans la cohorte FAITH
Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study
Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population‐based study in France
Guillaume Moulis, Maryse Lapeyre‐Mestre, Matthieu Mahévas, Jean‐Louis Montastruc and Laurent Sailler American Journal of Hematology 90(4) 301 (2015) https://doi.org/10.1002/ajh.23930
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: comment
G. Moulis, L. Sailler and M. Lapeyre‐Mestre Journal of Thrombosis and Haemostasis 13(8) 1521 (2015) https://doi.org/10.1111/jth.12984
Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study